학술논문

Cabergoline in the Management of Residual Nonfunctioning Pituitary Adenoma: A Single-Center, Open-Label, 2-Year Randomized Clinical Trial.
Document Type
Article
Source
American Journal of Clinical Oncology; Feb2019, Vol. 42 Issue 2, p221-227, 7p
Subject
Language
ISSN
02773732